Johns Michael R
Known title: VP - Gen Counsel & Corp SecCIK: 0001395287
Associated companies
Transaction History
| ARCB | ▼ Sell | Tax Withholding | 158 | $9K | 5/7/2025 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 274 | $16K | 5/6/2025 | View on chart |
| ARCB | ▲ Buy | Grant | 3,700 | $0 | 5/6/2025 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 264 | $16K | 5/5/2025 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 4,802 | $564K | 5/12/2024 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 1,118 | $131K | 5/11/2024 | View on chart |
| ARCB | ▲ Buy | Grant | 1,675 | $0 | 5/7/2024 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 424 | $50K | 5/6/2024 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 368 | $42K | 5/5/2024 | View on chart |
| ARCB | ▼ Sell | Open Market | 8,947 | $997K | 8/9/2023 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 3,310 | $287K | 5/9/2023 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 428 | $38K | 5/6/2023 | View on chart |
| ARCB | ▲ Buy | Grant | 2,800 | $0 | 5/5/2023 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 1,998 | $176K | 8/1/2022 | View on chart |
| ARCB | ▼ Sell | Tax Withholding | 4,420 | $328K | 5/12/2022 | View on chart |
| ARCB | ▲ Buy | Grant | 2,900 | $0 | 5/6/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ArcBest Unveils New View Features Amid Earnings Outlook
ArcBest has introduced new features in its ArcBest View platform, expanding its digital offerings. Analysts are debating whether the company will exceed earnings expectations in the next report, while some reports highlight potential drawbacks. The stock sits near a key support level and its RSI is in a neutral zone, reflecting a balanced market view.
ArcBest Unveils New View Features Amid Earnings Outlook. ArcBest has introduced new features in its ArcBest View platform, expanding its digital offerings. Analysts are debating whether the company will exceed earnings expectations in the next report, while some reports highlight potential drawbacks. The stock sits near a key support level and its RSI is in a neutral zone, reflecting a balanced market view.